[Cardiorenal syndrome - biomarkers and mediators]

Area of Science:

• Cardiorenal medicine
• Biomarker research
• Endocrinology

Background:

• Cardiorenal syndrome (CRS) is a complex condition with serious prognosis and limited treatment success.
• Inflammatory and hormonal factors are recognized as key mediators in the initiation, development, and progression of CRS.
• The intricate relationship between cardiac and renal systems begins even in the asymptomatic phase of CRS.

Purpose of the Study:

• To investigate the role of inflammatory and hormonal factors as biomarkers in cardiorenal syndrome.
• To understand the mediating mechanisms between heart and kidney dysfunction in CRS.
• To explore potential therapeutic strategies targeting hormonal changes in CRS.

Main Methods:

• Review of current literature on cardiorenal syndrome biomarkers.
• Analysis of the involvement of inflammatory factors and circulated hormones in CRS.
• Discussion of the clinical significance of these mediators in CRS presentation.

Main Results:

• Biomarkers, including inflammatory factors and hormones, play a significant role in mediating the cardiorenal interaction.
• These mediators are involved from the early, asymptomatic stages of CRS development.
• The complex interplay of these factors contributes to the poor prognosis of symptomatic CRS.

Conclusions:

• Identifying and correcting early changes in biomarkers is a significant clinical challenge.
• Monitoring and modulating hormonal changes present a promising therapeutic approach for managing cardiorenal syndrome.
• Further research into these mediators could lead to improved diagnostic and therapeutic strategies for CRS.